With Ebola cases petering out, will trial of the drug ZMapp run out of time?

Two of the antibodies were isolated and cloned by scientists at the Winnipeg lab while the third was developed by researchers at the U.S. Army Medical Research Institute of Infectious Diseases in Frederick, Md. Both labs had created unique versions of a three-antibody cocktail, both of which showed...

Full description

Saved in:
Bibliographic Details
Published inThe Canadian Press
Main Author Branswell, Helen
Format Newsletter
LanguageEnglish
Published Toronto Canadian Press Enterprises Inc 13.08.2015
Subjects
Antibodies
Clinical trials
Ebola virus
Immunoglobulins
Infectious diseases
Medical research
Studies
Toronto, Ontario
Online AccessGet full text

Cover

More Information
Summary:Two of the antibodies were isolated and cloned by scientists at the Winnipeg lab while the third was developed by researchers at the U.S. Army Medical Research Institute of Infectious Diseases in Frederick, Md. Both labs had created unique versions of a three-antibody cocktail, both of which showed promise when tested in non-human primates.